|
| 3 months evaluation N = 74 | Evaluation after end of adjuvant treatment N = 74 | Statistical significance# | ||
| Improvement | Deterioration | Improvement | Deterioration | P value* | |
| No (%) | No (%) | No (%) | No (%) |
| |
| Breast size | 8 (10.8) | 3 (4) | 12 (16.2) | 2 (2.7) | 0.028 |
| Breast shape | 18 (24.3) | 2 (2.7) | 19 (25.7) | 1 (1.35) | < 0.001 |
| Scar visibility | 1 (1.35) | 2 (2.7) | 4 (5.4) | 2 (2.7) | 0.41 |
| Nipple position | 5 (6.75) | 2 (2.7) | 7 (9.45) | 1 (1.35) | 0.033 |
| Skin color | 1 (1.35) | 1 (1.35) | 4 (5.4) | Zero (0) | 0.046 |
| Donor site | 74 (100) | Zero (0) | 74 (100) | Zero (0) | <0.001 |